About Dhavit
Dhavit is a Healthcare company based in India. It produces pharmaceutical products including nutraceuticals and therapies for health improvement. It operates on a B2B and D2C model. Its Indian entity Dhavit Global Life Sciences Private Limited reported revenue of ₹2.36 Cr. Dhavit offers products and services including Dhavpro, Fevmef, Dhaviflam, Dhavpraz, and Dhaviclav. Its focus areas include Nutraceuticals, Wellness Products, Supplements and Pharmaceuticals.
Company details
Dhavit is a pharmaceutical company focused on innovative healthcare solutions, born from compassion for global needs. It operates a modern manufacturing facility in Maharashtra, India, producing oral solids, nutraceuticals, and cosmeceuticals. The company emphasizes affordable therapies like probiotics and pain management, serving Indian states and expanding internationally to enhance quality of life through value-based innovation.
- Annual Revenue₹2.36 Cr
FY 2021
- Net Loss-₹93 Lakh
FY 2021 · -39% margin
- EBITDA-₹83.3 Lakh
FY 2021 · -35% margin
Associated legal entities of Dhavit
Dhavit operates through Dhavit Global Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2021) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dhavit Global Life Sciences Private Limited CIN U24304PN2018PTC174438 | Active | 18 Jan 2018 | Solapur, Maharashtra | ₹2.4 Cr | 66 | 6 | View details |
Products & Services of Dhavit
Dhavit offers a comprehensive portfolio of products and services, including Dhavpro, Fevmef, Dhaviflam, Dhavpraz, and Dhaviclav.
Probiotic supplement for improving gut health and immunity.
Medication for fever and pain relief in adults.
Anti-inflammatory drug for reducing pain and inflammation.
Proton pump inhibitor for treating acid-related disorders.
Antibiotic for bacterial infections and related treatments.
Board of directors of Dhavit Global Life Sciences Private Limited (Dhavit)
Dhavit Global Life Sciences Private Limited is the primary company behind Dhavit. The board of Dhavit Global Life Sciences Private Limited currently have 6 directors; the longest-serving is Suresh Mallikarjun Katgaon, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suresh Mallikarjun Katgaon DIN 02968408 | Director | 18 Jan 2018 | 8 yrs 9 mo | Dhavit Global Life Sciences Private Limited |
| Surekha Mallikarjun Katgaon DIN 02949488 | Director | 18 Jan 2018 | 8 yrs 9 mo | Dhavit Global Life Sciences Private Limited |
| Hariharan Rajeev DIN 08724997 | Additional Director | 01 Jun 2020 | 6 yrs 5 mo | Dhavit Global Life Sciences Private Limited |
| Appasha Umadi DIN 07226999 | Additional Director | 01 Jun 2020 | 6 yrs 5 mo | Dhavit Global Life Sciences Private Limited |
| Milind Ramakrishna Kulkarni DIN 07508657 | Director | 01 Jun 2020 | 6 yrs 5 mo | Dhavit Global Life Sciences Private Limited |
| Santosh Moreshwar Savarkar DIN 08223116 | Director | 01 Jun 2020 | 6 yrs 5 mo | Dhavit Global Life Sciences Private Limited |
Financials of Dhavit
Figures of Dhavit Global Life Sciences Private Limited, the primary company behind Dhavit, for FY 2021. Revenue was ₹2.36 Cr. Net loss was -₹93 Lakh (-39% margin). EBITDA was -₹83.3 Lakh (-35% margin).
- ₹2.36 CrRevenue · FY 2021
- -₹93 LakhNet loss · -39% margin
- -₹83.3 LakhEBITDA · -35% margin
- ₹1.00 CrPaid-up capital
- 66Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Dhavit Global Life Sciences Private Limited are on its company page.
Detailed financial statements for Dhavit
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Alternative Medicine Products
3 companies that operate in the same segment as Dhavit (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Homeopathic medicine manufacturing and online retail in India. | 1898 | Noida, Uttar Pradesh, India | USD 26.35 M | 1,192 | ||
Operates an online store specializing in ayurvedic and homeopathic medicines. | 2016 | Delhi, Delhi, India | USD 1.25 M | 16 | ||
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness. | 1992 | Faridabad, Haryana, India | USD 10.08 M | 570 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dhavit
Dhavit is headquartered in India.
The primary company behind Dhavit, Dhavit Global Life Sciences Private Limited, reported revenue of ₹2.36 Cr for FY 2021.
Dhavit is a pharmaceutical company focused on innovative healthcare solutions, born from compassion for global needs. It operates a modern manufacturing facility in Maharashtra, India, producing oral solids, nutraceuticals, and cosmeceuticals. The company emphasizes affordable therapies like probiotics and pain management, serving Indian states and expanding internationally to enhance quality of life through value-based innovation.
Dhavit offers Dhavpro, Fevmef, Dhaviflam, Dhavpraz, and Dhaviclav.
Dhavit operates through Dhavit Global Life Sciences Private Limited.
The legal entities of Dhavit currently have 6 directors, including Hariharan Rajeev, Appasha Umadi, Milind Ramakrishna Kulkarni and others.